SCHEMBL7515780

SCHEMBL7515780

CCCCCCOc1cc2ccc(-c3ccc(C(=O)O)c(O)c3)cc2cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 7/20 0.51
RARG P13631 7/20 0.51
RARA P10276 4/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
THRB P10828 1/20 0.51
RECQL P46063 1/20 0.51
NR2E1 Q9Y466 1/20 0.51
NR1I2 O75469 1/20 0.51
LMNA P02545 1/20 0.51
PGR P06401 1/20 0.51
HSPD1 P10809 1/20 0.51
GOT1 P17174 1/20 0.51
GLRA1 P23415 1/20 0.51
BLM P54132 1/20 0.51
HSPE1 P61604 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7927670 0.91 RARB (0.47) RARBRARGRARAMEN1KMT2A
SCHEMBL7521122 0.88 MEN1 (0.61) RARBRARGRARAMEN1KMT2A
SCHEMBL8458019 0.86 PTPN11 (0.58) RARBRARGRARAMEN1KMT2A
SCHEMBL2919467 0.84 IKBKB (0.52) RARBRARGRARAMEN1KMT2A
SCHEMBL29462745 0.84 IKBKB (0.52) RARBRARGRARAMEN1KMT2A
SCHEMBL7517611 0.83 MEN1 (0.53) RARBRARGRARAMEN1KMT2A
SCHEMBL7920651 0.83 RARB (0.54) RARBRARGRARAMEN1KMT2A
SCHEMBL980744 0.82 RARB (0.72) RARBRARGRARAMEN1KMT2A
SCHEMBL979218 0.82 RARB (0.72) RARBRARGRARAMEN1KMT2A
SCHEMBL1684004 0.81 RARB (0.48) RARBRARGRARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1104896-C 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor GALDERMA RECH DERMATOLOGIQUE (FR) 2003-04-09 CN claimed
EP-0854711-B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR GALDERMA RECH DERMATOLOGIQUE (FR) 2002-01-23 EP claimed
US-6063797-A γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor C.I.R.D. GALDERMA (FR) 2000-05-16 US claimed
CN-1203529-A RAR-gamma antagonist ligands or RAR-alpha agonist ligands as apoptosis inhibitors CIRD GALDERMA (FR) 1998-12-30 CN claimed
EP-0658553-B1 Polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof CIRD GALDERMA (FR) 1998-11-04 EP claimed
CN-1104896-C 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor GALDERMA RECH DERMATOLOGIQUE (FR) 2003-04-09 CN disclosed
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
US-6063797-A γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor C.I.R.D. GALDERMA (FR) 2000-05-16 US disclosed
CN-1203529-A RAR-gamma antagonist ligands or RAR-alpha agonist ligands as apoptosis inhibitors CIRD GALDERMA (FR) 1998-12-30 CN disclosed
EP-0658553-B1 Polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof CIRD GALDERMA (FR) 1998-11-04 EP disclosed
EP-0740937-A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1996-11-06 EP disclosed
EP-0658553-A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-06-21 EP disclosed